Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer EntitiesWolfgang P. Fendler, Rainer Hamacher, Ken Herrmann et al.|Clinical Cancer Research|2022Cited by 145
Intraoperative <sup>68</sup>Ga-PSMA Cerenkov Luminescence Imaging for Surgical Margins in Radical Prostatectomy: A Feasibility StudyChristopher Darr, Boris Hadaschik, Wolfgang P. Fendler et al.|Journal of Nuclear Medicine|2020Cited by 43
Fibroblast Activation Protein α–Directed Imaging and Therapy of Solitary Fibrous TumorRainer Hamacher, Wolfgang P. Fendler, Daniel Hübschmann et al.|Journal of Nuclear Medicine|2024Cited by 26
The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma: A Comparison of Tissue,<sup>68</sup>Ga-FAPI-46 PET Data, and Survival DataChristoph Oster, Martin Glas, Christoph Kleinschnitz et al.|Journal of Nuclear Medicine|2024Cited by 11
<sup>90</sup>Y-FAPI-46 Theranostics Leads to Near-Complete Metabolic Response in 3 Patients with Solitary Fibrous TumorsHelena Lanzafame, Rainer Hamacher, Stefan Fröhling et al.|Journal of Nuclear Medicine|2025Cited by 10